C-type natriuretic peptide and guanylyl cyclase B receptor

被引:91
作者
Schulz, S [1 ]
机构
[1] Thomas Jefferson Univ, Div Clin Pharmacol, Dept Med, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Div Clin Pharmacol, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA
关键词
guanylyl cyclase; cGMP; C-type natriuretic peptide;
D O I
10.1016/j.peptides.2004.08.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Guanylyl cyclases (GC) are widely distributed enzymes that signal via the production of the second messenger cGMP. The particulate guanylyt cyclases share a similar topology: an extracellular ligand binding domain and intracellular regulatory kinase-hornology and cyclase catalytic domains. The natriuretic peptide receptors GC-A and -B mediate the effects of a family of peptides. atrial. B- and C-type natriuretic peptide (ANP, BNP and CNP, respectively), with natriuretic, diuretic and vasorelaxant properties. ANP and BNR through the activation of GC-A, act as endocrine hormones to regulate blood pressure and volume. and inhibit cardiac hypertrophy. CNP on the other hand. acts in an autocrine/paracrine fashion to induce vasorelaxation and vascular remodeling, and to regulate bone growth through its Cognate receptor GC-B. GC-B, like GC-A, is phosphorylated in the basal state, and undergoes both homologous and heterologous desensitization. reflected by dephosphorylation of specific sites in the kinase-homology domain. This review will examine the structure and function of GC-B, and summarize the physiological processes in which this receptor is thought to participate. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1024 / 1034
页数:11
相关论文
共 146 条
[1]   Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B [J].
Abbey, SE ;
Potter, LR .
ENDOCRINOLOGY, 2003, 144 (01) :240-246
[2]   Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations [J].
Abbey, SE ;
Potter, LR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42423-42430
[3]   Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs [J].
Beaulieu, P ;
Cardinal, R ;
DeLean, A ;
Lambert, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (07) :1790-1796
[4]  
BEAULIEU P, 1997, AM J PHYSIOL-HEART C, V273, pH1933
[5]   Mouse models orthologous to FGFR3-related skeletal dysplasias [J].
Brodie, SG ;
Deng, CX .
PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2003, 22 (01) :87-103
[6]   REGIONAL EXPRESSION OF NATRIURETIC PEPTIDE RECEPTORS DURING THE FORMATION OF ARTERIAL NEOINTIMA IN THE RABBIT [J].
BROWN, J ;
CHEN, Q .
CIRCULATION RESEARCH, 1995, 77 (05) :906-918
[7]   NATRIURETIC PEPTIDE RECEPTORS IN THE FETAL-RAT [J].
BROWN, J ;
ZUO, Z .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (02) :E253-E268
[8]   Arm autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair [J].
Brown, J ;
Chen, Q ;
Hong, GZ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (06) :H2919-H2931
[9]   Effects of C-type natriuretic peptide on rat cardiac contractility [J].
Brusq, JM ;
Mayoux, E ;
Guigui, L ;
Kirilovsky, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (01) :206-212
[10]   The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: Temporal changes in embryos and placenta [J].
Cameron, VA ;
Aitken, GD ;
Ellmers, LJ ;
Kennedy, MA ;
Espiner, EA .
ENDOCRINOLOGY, 1996, 137 (03) :817-824